Xylazine (Rompun) is an α2 class of adrenergic receptor agonist. Xylazine is a clonidine analoque that acts on presynaptic and postsynaptic receptors of the central and peripheral nervous systems as an a 2-adrenergic agonist.
Schwartz, D.D., and Clark, T.P., Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypes. J. Vet. Pharmacol. Ther. 21, 107-111, (1998) Ware, T.D., and Paul, D., Cross-tolerance between analgesia produced by xylazine and selective opioid receptor subtype treatments. Eur. J. Pharmacol. 389, 181-185, (2000) Cabral, A.D., et al., Central å2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am. J. Physiol. 275, R1867-R1874, (1998)
See how others have used Xylazine (CAS 7361-61-7). Click on the entry to view the PubMed entry .
PMID: # 30260620 Rzagalinski, I.|Kovačević, B.|Hainz, N.|Meier, C.|Tschernig, T.|Volmer, DA.| et al. 2018. Anal. Chem. 90: 12592-12600.
PMID: # 32299465 J Neuroinflammation. 17: 120.
PMID: # 30385718 JCI Insight. 3:
PMID: # 32555306 Sci Rep. 9898.
PMID: # 32179986 Parasitol. Res. 1301-1315.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.